Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anterior ischemic optic neuropathy.

A C Arnold1

  • 1UCLA Optic Neuropathy Center, Jules Stein Eye Institute, Department of Ophthalmology 90024-7005, USA.

Seminars in Ophthalmology
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Eye (London, England)·2014
Same author

Effectiveness of various compounds against Coccidioides immitis.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Side effect of head and neck radiotherapy: optic neuropathy.

Oftalmologia (Bucharest, Romania : 1990)·2008
Same author

Ischemic optic neuropathies.

Ophthalmology clinics of North America·2001
Same author

Systemic disease and neuro-ophthalmology: annual update 2000 (Part I).

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2001
Same author

Horner's syndrome and dissection of the internal carotid artery after chiropractic manipulation of the neck.

American journal of ophthalmology·2001
Same journal

Longitudinal Structural and Functional Trajectories Following Netarsudil Intensification or Surgical Escalation in Primary Open-Angle Glaucoma.

Seminars in ophthalmology·2026
Same journal

Maternal Diabetes Mellitus During Pregnancy as a Risk Factor for Congenital Nasolacrimal Duct Obstruction in the Offspring - a Large-Scale National Study.

Seminars in ophthalmology·2026
Same journal

Clinical Spectrum and Genetics of Ocular Manifestations in Muscle Eye Brain Disease: A Literature Review.

Seminars in ophthalmology·2026
Same journal

Port Delivery System Vs Monthly Ranibizumab in VEGF-Driven Macular Disease: A Systematic Review and Meta-Analysis.

Seminars in ophthalmology·2026
Same journal

Genome Wide Pleiotropic Analysis Reveals Shared Genetic Architecture and Pathological Basis Between Retinitis Pigmentosa and Relevant Ocular Comorbidities.

Seminars in ophthalmology·2026
Same journal

Does QuantiFERON-Positive Tubercular Serpiginous-Like Choroiditis Affect Retinal and Choroidal Structures Differently in Affected Eyes Compared to Fellow Eyes and Healthy Controls? A Comparative OCT and OCT-A Study.

Seminars in ophthalmology·2026
See all related articles

Arteritic anterior ischemic optic neuropathy (AION) is common in those over 50. While diagnosis is simple, current treatments for vision loss are insufficient, necessitating further research for effective therapies.

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Arteritic anterior ischemic optic neuropathy (AION) is the most frequent acute optic neuropathy in individuals over 50 years of age.
  • Despite straightforward diagnostic criteria, current therapeutic strategies for managing AION-associated visual impairment remain inadequate.

Purpose of the Study:

  • To review recent clinical studies on AION.
  • To identify potential advancements in managing visual loss due to AION.

Main Methods:

  • Systematic review of recent clinical research on AION.
  • Analysis of data from clinical trials and observational studies.

Main Results:

  • Current management strategies for AION show limited efficacy in restoring vision.

Related Experiment Videos

  • Recent studies highlight areas for potential therapeutic development.

    • Conclusions:

    • There is a critical need for more effective treatments for visual loss in AION.
    • Further analysis of clinical data may pave the way for improved therapeutic interventions for AION.